Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$4.7 - $9.87 $19,669 - $41,305
-4,185 Reduced 13.96%
25,804 $169,000
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $29,970 - $42,135
3,279 Added 12.28%
29,989 $299,000
Q2 2023

Aug 14, 2023

BUY
$12.09 - $15.0 $79,781 - $98,985
6,599 Added 32.81%
26,710 $332,000
Q1 2023

May 12, 2023

BUY
$12.99 - $16.48 $261,241 - $331,429
20,111 New
20,111 $281,000
Q1 2022

May 11, 2022

SELL
$24.46 - $40.92 $273,144 - $456,953
-11,167 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$35.0 - $45.94 $390,845 - $513,011
11,167 New
11,167 $468,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $723M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.